Parameters of macrophage reaction and humoral immunity in patients with implant-associated in-flammation after primary endoprosthetics of knee joint

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To study peculiarities of macrophage reaction and humoral immunity in patients with signs of implant-associated inflammation after the primary endoprosthetics of the knee joint.

Materials and Methods. Examination of 48 patients with signs of implant-associated inflammation after the primary endoprosthetics of the knee joints (the main group) and of 44 patients without signs of inflammatory reactions (comparison group) was carried out. Control group involved 30 healthy donors without diseases of the musculoskeletal system.

Results. In 1 and 12 months after the surgery, patients of the main group showed elevated levels of the factor inhibiting migration of macrophages (MIF), of macrophage stimulating protein (MSP), class A immunoglobulins (IgA), С3 and С4 complement components as compared to control, and also to each previous period. In 1 month after the surgery, the content of class M and G immunoglobulins (IgM and IgG) decreased relative to control; in 12 months after the surgery a more pronounced reduction was noted. Increase in serum concentrations of MIF, MSP, IgA, С3 and С4-complement components was noted in the comparison group in 1 and 12 months and also in comparison with the previous period. Reduction of the levels of IgM, IgG in 1 and 12 months after the operation was noted in comparison with control and with the previous period.

Conclusion. A study of parameters of macrophage reaction, proteins of complement system and the main classes of immunoglobulins permits to identify signs of implant-associated inflammation in 1 and 12 months after surgery, and, consequently, to determine patients of risk groups that require additional diagnostics measures.

Full Text

Restricted Access

About the authors

Elena A. Galashina

Scientific Research Institute of Traumatology, Orthopedics and Neurosurgery Razumovsky Saratov State Medical University

Author for correspondence.
Email: koniuchienko1983@mail.ru
ORCID iD: 0000-0001-6209-9120
SPIN-code: 4016-0672
Scopus Author ID: 57190286406
ResearcherId: V-9086-2017
https://www.sarniito.com/

PhD in Biological Sciences, Junior Researcher of the
Department of Fundamental, Clinical and Experimental Researches

Russian Federation, Saratov

Ekaterina V. Gladkova

Scientific Research Institute of Traumatology, Orthopedics and Neurosurgery Razumovsky Saratov State Medical University

Email: gladkowa.katya@yandex.ru
ORCID iD: 0000-0002-6207-2275
SPIN-code: 3837-3244
Scopus Author ID: 36722610700
ResearcherId: V-9077-2017
https://www.sarniito.com/

PhD in Biological Sciences, Head of the Department of Fundamental, Clinical and Experimental Researches

Russian Federation, Saratov

Veronika V. Blinnikova

Scientific Research Institute of Traumatology, Orthopedics and Neurosurgery Razumovsky Saratov State Medical University

Email: bib@sarniito.com

MD, PhD, Doctor of the Clinical Laboratory Diagnostics Department

Russian Federation, Saratov

Sergey P. Shpinyak

Scientific Research Institute of Traumatology, Orthopedics and Neurosurgery Razumovsky Saratov State Medical University

Email: sergos83@rambler.ru
ORCID iD: 0000-0002-0345-6287
SPIN-code: 6540-1764
Scopus Author ID: 57191473935
ResearcherId: A-8021-2018

MD, PhD, Junior Researcher of the Innovative Projects for Traumatology and Orthopedics Department

Russian Federation, Saratov

Vladimir Y. Ulyanov

Scientific Research Institute of Traumatology, Orthopedics and Neurosurgery Razumovsky Saratov State Medical University

Email: v.u.ulyanov@gmail.com
ORCID iD: 0000-0002-9466-8348
SPIN-code: 8280-3339
Scopus Author ID: 56527335300
ResearcherId: A-4073-2014
https://www.sarniito.com/

MD, PhD, Deputy Director for Science and Innovations, Scientific Research Institute of Traumatology

Russian Federation, Saratov

References

  1. Bolotkan uulu Nasyr. Prophylaxis of infectious complications of endoprothesis of knee joint. Vestnik KSMA im. I.K. Akhunbayeva. 2015;(1):69-73. (In Russ).
  2. Filipenko VA, Marushchak AP, Bondarenko SYe. Periprosthetic infection: diagnostic and treatment. Part I (literature review). Orthopaedics, Traumatology and Prosthetics. 2016;(2):102-9. (In Russ).
  3. Tikhomirov DA, Schekolova NB. Experience of treatment of infectious complications after primary hip joint endoprosthesis replacement. Permskiy Meditsinskiy Zhurnal. 2016;33(4):28-32. (In Russ).
  4. Tsibulkina VN, Akhtyamov, IPh, Kilmetov TA. Immunological aspects of pyoinflammatory complications after endoprosthesis replacement of large joints. Practical Medicine. 2016;(4-2):161-4. (In Russ).
  5. Shakhidzhanov SS, Filippova AE, Butilin AA, et al. A modern view on the complement system. Pediatric Hematology/Oncology and Immunopathology. 2019;18(3):133-40. (In Russ). doi: 10.24287/1726-1708-2019-18-3-130-144
  6. Litvitskiy PF, Sinel'nikova TG. Innate immunity: mechanisms of realization and pathological syndromes. Part III. Voprosy Sovremennoi Pediatrii. 2009;8(3):54-65. (In Russ).
  7. Galashina EA, Ulyanov VYu, Gladkova EV, et al. Comparative analysis of the change of bone tissue metabolism condition and cytokine profiles in patients with endoprosthesis instability after primary knee arthroplasty. I.P. Pavlov Russian Medical Biological Herald. 2020;28(1):5-12. (In Russ). doi: 10.23888/PAVLOVJ20202815-12
  8. Vodopyanov AS, Dudnikova EV, Dergousova MS, et al. The role of macrophage migration inhibitory factor in chronization of pathological process (references). Meditsinskiy Vestnik Yuga Rossii. 2013; (3):4-7. (In Russ).
  9. Rampino Т, Сollesi C, Gregorini M, et al. Macrophage-stimulating protein is produced by tubular cells and activates mesangial cells. Journal of the American Society of Nephrology. 2002;13(3):649-57.
  10. Gladkova EV, Mamonova IA, Babushkina IV, et al. The features of immune status in elderly and senile patients after total replacement of large joints. International Journal of Applied and Fundamental Research. 2017;(6 Pt 1):107-10. (In Russ).
  11. Chebotar IV. Mechanisms of antibiofilm immunity. Annals of the Russian academy of medical sciences. 2012;(12):22-9. (In Russ).
  12. Kilmetov ТА, Lapshina SA, Ardashev SA. Infectious complications after replacement of a large joints. Practical Medicine. 2015;1(4):76-8. (In Russ).
  13. Pan X, Mao X, Cheng T, et al. Upregulated expression of MIF by interfacial membrane fibroblasts and macrophages around aseptically loosened implants. The Journal of Surgical Research. 2012;176(2):484-9. doi: 10.1016/j.jss.2011.09.047
  14. Thordardottir S, Vikingsdottir T, Bjarnadottir H, et.al. Activation of Complement Following Total Hip Replacement. Scandinavian Journal of Immunology. 2016;83(3):219-24. doi: 10.1111/sji.12411

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Eco-Vector


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies